Company profile
UK company 13593877, incorporated on 31 August 2021.
Bloomsbury Genetic Therapies Dedicated to delivering the promise of gene therapy
Bloomsbury Genetic Therapies Limited is a UK company with status active founded in 2021 based in East of England.
Company number 13593877
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
CS01 | Transaction MzU0Njc0ODgwMGFkaXF6a2N4
Published 24 Sep 2026 07:23
Company registered at Companies House
Bloomsbury Genetic Therapies utilises gene therapies to develop treatments for rare neurological and metabolic diseases.
The company aims to translate AAV gene therapy programmes in to paediatric patients affected by rare genetic diseases.
The company was created end of 2021 and will take over some academic projects, including the HORACE trial for paediatric ornithine transcarbamylase deficient patients.
The company has just formed but the first clinical trial will start imminently for one of the programmes and another of the programmes has just been granted orphan drug designation.
Not yet
